The global capsule endoscopy market size attained a value of USD 882.8 million in 2022. The market is anticipated to grow at a CAGR of 8.7% during the forecast period of 2023-2031 to attain a value of USD 1870.3 million by 2031.
The procedure involves the patient swallowing a small capsule, about the size of a large vitamin pill, which contains a tiny wireless camera. As the capsule travels through the gastrointestinal tract, it takes thousands of pictures that are transmitted to a recorder the patient wears on a belt around their waist. The images can then be downloaded onto a computer, where the doctor can view them. The capsule is eventually expelled naturally from the body in the stool.
Capsule endoscopy is primarily used to visualize parts of the gastrointestinal tract that cannot be seen with other types of endoscopies such as colonoscopy or esophagogastroduodenoscopy. It is often used to help diagnose conditions such as Crohn's disease, celiac disease, or gastrointestinal bleeding of unknown origin. It can also be used to examine the oesophagus or colon, though this is less common.
2. Esophageal
3. Colon
In terms of prevalence, the increasing occurrence of conditions such as Crohn's disease, colorectal cancer, and peptic ulcers, among others, drives the demand for capsule endoscopy. This procedure provides a minimally invasive, comprehensive method for visualizing the entirety of the small intestine and detecting these diseases.
The aging population worldwide is another significant factor contributing to the market's expansion. As age is a major risk factor for many gastrointestinal diseases, the demand for capsule endoscopy is expected to rise with an increase in the elderly population.
Technological advancements have also played a vital role in propelling the market. Modern capsule endoscopy systems have evolved significantly, offering improved imaging capabilities, longer battery life, and greater patient comfort. The development of capsules with adjustable frame rates and view angles, as well as those that can transmit real-time images, are some of the innovations that are encouraging the adoption of this technology.
Furthermore, the preference for non-invasive procedures over conventional endoscopy methods boosts the growth of the capsule endoscopy market. The convenience and comfort associated with swallowing a capsule, as opposed to the invasiveness of traditional endoscopy, make it an attractive option for both doctors and patients.
Geographically, North America and Europe hold significant shares of the market due to the presence of advanced healthcare infrastructure, increased awareness, and higher healthcare expenditure. However, the Asia-Pacific region is expected to witness rapid growth due to the large patient population, rising incidence of gastrointestinal diseases, and improving healthcare facilities.
However, there are challenges facing the market. The high cost of capsule endoscopy systems and the fact that capsule endoscopy cannot perform therapeutic interventions like biopsies or polyp removals are some factors that may limit market growth.
Overall, the capsule endoscopy market is poised for substantial growth due to the rising demand for non-invasive diagnostic procedures, the increasing prevalence of gastrointestinal diseases, and continuous technological advancements in the field.
Capsule Endoscopy Market: Introduction
Capsule endoscopy is a non-invasive, diagnostic procedure that allows a doctor to examine the lining of the middle part of the gastrointestinal tract, which includes the three portions of the small intestine (duodenum, jejunum, and ileum).The procedure involves the patient swallowing a small capsule, about the size of a large vitamin pill, which contains a tiny wireless camera. As the capsule travels through the gastrointestinal tract, it takes thousands of pictures that are transmitted to a recorder the patient wears on a belt around their waist. The images can then be downloaded onto a computer, where the doctor can view them. The capsule is eventually expelled naturally from the body in the stool.
Capsule endoscopy is primarily used to visualize parts of the gastrointestinal tract that cannot be seen with other types of endoscopies such as colonoscopy or esophagogastroduodenoscopy. It is often used to help diagnose conditions such as Crohn's disease, celiac disease, or gastrointestinal bleeding of unknown origin. It can also be used to examine the oesophagus or colon, though this is less common.
The benefits of capsule endoscopy include:
- Non-Invasive: As the procedure does not involve anaesthesia or sedation, it is less invasive than traditional endoscopy. There is also no risk of perforation or bleeding
- Comprehensive: It allows for a detailed examination of the small intestine, an area that is difficult to visualize with traditional endoscopy procedures
- Comfortable: As the capsule is simply swallowed like a pill, most patients find the procedure comfortable
- Functional: It allows for visualization of the gastrointestinal tract in its functioning state, which can provide valuable information about motility disorders
Capsule Endoscopy Market Segmentations
The market can be categorised into product type, application, end user, and region.Capsule Endoscopy Market Breakup by Product type
- Capsule Endoscopes
2. Esophageal
3. Colon
- Systems
Capsule Endoscopy Market Breakup by Application
- OGIB (obscure GI tract bleeding)
- Crohn’s Disease
- Small Intestine Tumor
- Others
Capsule Endoscopy Market Breakup by End user
- Hospitals
- Ambulatory Surgical Centers
- Others
Capsule Endoscopy Market Breakup by Region
North America
- United States of America
- Canada
Europe
- United Kingdom
- Germany
- France
- Italy
- Others
Asia Pacific
- China
- Japan
- India
- ASEAN
- Australia
- Others
Latin America
- Brazil
- Argentina
- Mexico
- Others
Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Nigeria
- South Africa
- Others
Capsule Endoscopy Market Scenario
The global capsule endoscopy market continues to grow, fuelled by a rise in the prevalence of gastrointestinal diseases, an aging global population, and technological advancements in capsule endoscopy systems.In terms of prevalence, the increasing occurrence of conditions such as Crohn's disease, colorectal cancer, and peptic ulcers, among others, drives the demand for capsule endoscopy. This procedure provides a minimally invasive, comprehensive method for visualizing the entirety of the small intestine and detecting these diseases.
The aging population worldwide is another significant factor contributing to the market's expansion. As age is a major risk factor for many gastrointestinal diseases, the demand for capsule endoscopy is expected to rise with an increase in the elderly population.
Technological advancements have also played a vital role in propelling the market. Modern capsule endoscopy systems have evolved significantly, offering improved imaging capabilities, longer battery life, and greater patient comfort. The development of capsules with adjustable frame rates and view angles, as well as those that can transmit real-time images, are some of the innovations that are encouraging the adoption of this technology.
Furthermore, the preference for non-invasive procedures over conventional endoscopy methods boosts the growth of the capsule endoscopy market. The convenience and comfort associated with swallowing a capsule, as opposed to the invasiveness of traditional endoscopy, make it an attractive option for both doctors and patients.
Geographically, North America and Europe hold significant shares of the market due to the presence of advanced healthcare infrastructure, increased awareness, and higher healthcare expenditure. However, the Asia-Pacific region is expected to witness rapid growth due to the large patient population, rising incidence of gastrointestinal diseases, and improving healthcare facilities.
However, there are challenges facing the market. The high cost of capsule endoscopy systems and the fact that capsule endoscopy cannot perform therapeutic interventions like biopsies or polyp removals are some factors that may limit market growth.
Overall, the capsule endoscopy market is poised for substantial growth due to the rising demand for non-invasive diagnostic procedures, the increasing prevalence of gastrointestinal diseases, and continuous technological advancements in the field.
Key Players in the Global Capsule Endoscopy Market
The report gives an in-depth analysis of the key players involved in the capsule endoscopy market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:- Boston Scientific Corporation
- CapsoCam Plus
- ConMed Corporation
- Cook
- The Guidant Group
- INTROMEDIC
- JINSHAN Science & Technology
- Medtronic
- Olympus Corporation
- RF Co.,Ltd
- Fujifilm Holdings Corporation
- Check-Cap
- Accu-Read, INC.
Table of Contents
1 Preface
3 Global Capsule Endoscopy Market Overview
4 Global Capsule Endoscopy Market Landscape
5 Global Capsule Endoscopy Market Dynamics
6 Global Capsule Endoscopy Market Segmentation
7 North America Capsule Endoscopy Market
8 Europe Capsule Endoscopy Market
9 Asia Pacific Capsule Endoscopy Market
10 Latin America Capsule Endoscopy Market
11 Middle East and Africa Capsule Endoscopy Market
12 Patent Analysis
13 Grants Analysis
14 Funding Analysis
15 Partnership and Collaborations Analysis
16 Regulatory Framework
17 Supplier Landscape
18 Global Capsule Endoscopy Market - Distribution Model (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
21 Payment Methods (Additional Insight)
Companies Mentioned
- Boston Scientific Corporation
- Capsocam Plus
- Conmed Corporation
- Cook
- The Guidant Group
- Intromedic
- Jinshan Science & Technology
- Medtronic
- Olympus Corporation
- Rf Co. Ltd.
- Fujifilm Holdings Corporation
- Check-Cap.
- Accu-Read, Inc.
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 147 |
Published | April 2023 |
Forecast Period | 2023 - 2031 |
Estimated Market Value ( USD | $ 959.5 Million |
Forecasted Market Value ( USD | $ 1870.3 Million |
Compound Annual Growth Rate | 8.7% |
Regions Covered | Global |
No. of Companies Mentioned | 13 |